Christophe Arbet-engels - Net Worth and Insider Trading

Christophe Arbet-engels Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Christophe Arbet-engels owns 3 companies in total, including Millendo Therapeutics Inc (MLND) , Tempest Therapeutics Inc (TPST) , and X4 Pharmaceuticals Inc (XFOR) .

Click here to see the complete history of Christophe Arbet-engels’s form 4 insider trades.

Insider Ownership Summary of Christophe Arbet-engels

Ticker	Comapny	Transaction Date	Type of Owner
MLND	Millendo Therapeutics Inc	2020-05-25	Chief Medical Officer
TPST	Tempest Therapeutics Inc	2020-02-10	Chief Medical Officer
XFOR	X4 Pharmaceuticals Inc	2023-08-16	Chief Medical Officer

Christophe Arbet-engels Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Christophe Arbet-engels Ownership Network

Ownership Network List of Christophe Arbet-engels

No Data

Ownership Network Relation of Christophe Arbet-engels

Christophe Arbet-engels Owned Company Details

What does Millendo Therapeutics Inc do?

Who are the key executives at Millendo Therapeutics Inc?

Christophe Arbet-engels is the Chief Medical Officer of Millendo Therapeutics Inc. Other key executives at Millendo Therapeutics Inc include Chief Development Officer Ryan Zeidan , director & President and CEO Julia C. Owens , and General Counsel and Secretary Tamara L Joseph .

Millendo Therapeutics Inc (MLND) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Millendo Therapeutics Inc (MLND) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Millendo Therapeutics Inc (MLND) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Millendo Therapeutics Inc (MLND)'s detailed insider trading history can be found in Insider Trading Tracker table.

Millendo Therapeutics Inc Insider Transactions

No Available Data

What does Tempest Therapeutics Inc do?

Who are the key executives at Tempest Therapeutics Inc?

Christophe Arbet-engels is the Chief Medical Officer of Tempest Therapeutics Inc. Other key executives at Tempest Therapeutics Inc include Corporate Controller Justin Trojanowski , VP of Strategy and Finance Nicholas Maestas , and 10 percent owner Versant Side Fund Iv, L.p. .

Tempest Therapeutics Inc (TPST) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Tempest Therapeutics Inc (TPST) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Tempest Therapeutics Inc (TPST) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Tempest Therapeutics Inc (TPST)'s detailed insider trading history can be found in Insider Trading Tracker table.

Tempest Therapeutics Inc Insider Transactions

No Available Data

What does X4 Pharmaceuticals Inc do?

Who are the key executives at X4 Pharmaceuticals Inc?

Christophe Arbet-engels is the Chief Medical Officer of X4 Pharmaceuticals Inc. Other key executives at X4 Pharmaceuticals Inc include Chief Scientific Officer Arthur Taveras , Chief Operating Officer Mary Dibiase , and See Remarks Adam S. Mostafa .

X4 Pharmaceuticals Inc (XFOR) Insider Trades Summary

Over the past 18 months, Christophe Arbet-engels made no insider transaction in X4 Pharmaceuticals Inc (XFOR). Other recent insider transactions involving X4 Pharmaceuticals Inc (XFOR) include a net sale of 401,923 shares made by Paula Ragan , a net sale of 113,683 shares made by Mary Dibiase , and a net sale of 401,921 shares made by Adam S. Mostafa .

In summary, during the past 3 months, insiders sold 185,708 shares of X4 Pharmaceuticals Inc (XFOR) in total and bought 0 shares, with a net sale of 185,708 shares. During the past 18 months, 1,158,291 shares of X4 Pharmaceuticals Inc (XFOR) were sold and 25,000 shares were bought by its insiders, resulting in a net sale of 1,133,291 shares.

X4 Pharmaceuticals Inc (XFOR)'s detailed insider trading history can be found in Insider Trading Tracker table.

X4 Pharmaceuticals Inc Insider Transactions

No Available Data

Christophe Arbet-engels Mailing Address

Above is the net worth, insider trading, and ownership report for Christophe Arbet-engels. You might contact Christophe Arbet-engels via mailing address: C/o Millendo Therapeutics, Inc., 110 Miller Avenue, Suite 100, Ann Arbor Mi 48104.

Discussions on Christophe Arbet-engels

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.